Total revenues rose +5% (+7% at constant currencies (cc)) to USD4,420m and the gross profit margin was up from 31.7% to 30.9% in Q2 16. EBITDA increased +15% to USD835m and net income attributable to shareholders clearly improved by +22% to USD294m. Operating CF jumped +76% to USD678m, mainly driven by a swing in NWC from USD-106m to USD114m due to adjustments impacting the invoicing and timing of working capital items. Days sales outstanding declined from 74 days (Q1 16) to 70 days. Investin
02 Aug 2016
Good old Dialysis Service made the pace
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Good old Dialysis Service made the pace
Fresenius Medical Care AG (FME:WBO) | 0 0 0.7% | Mkt Cap: 26,769m
- Published:
02 Aug 2016 -
Author:
Martin Schnee -
Pages:
3
Total revenues rose +5% (+7% at constant currencies (cc)) to USD4,420m and the gross profit margin was up from 31.7% to 30.9% in Q2 16. EBITDA increased +15% to USD835m and net income attributable to shareholders clearly improved by +22% to USD294m. Operating CF jumped +76% to USD678m, mainly driven by a swing in NWC from USD-106m to USD114m due to adjustments impacting the invoicing and timing of working capital items. Days sales outstanding declined from 74 days (Q1 16) to 70 days. Investin